Abstract
MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene has been identified as an oncogene transcriptionally activated by t(6;14)(p25;q32) chromosomal translocation in multiple myeloma (MM). The significance of this alteration in MM remains unknown, as it is not detectable by means of conventional cytogenetic analysis. To address this issue, we established diagnostic procedures based on pulsed-field gel electrophoresis (PFGE) analysis and double color fluorescence in situ hybridization (DCFISH) using DNA probes derived from the MUM1 and the immunoglobulin heavy chain (IgH) gene loci. Among a panel of 17 MM cell lines, three (17.6%) showed fusions between these two loci, which resulted in the juxtaposition of the MUM1 to the IgH 3′ α-enhancer region by virtue of t(6;14) or insertion of the IgH sequences into the vicinity of the MUM1 gene and in the concomitant overexpression of the MUM1 mRNA. With similar results, fusions between MUM1 and IgH loci were observed by means of interphase DCFISH in eight (21.1%) out of the 38 MM cases, although no definite relationships between MUM1 status and specific clinical findings could be established.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clinical Relevance of Interferon Regulatory Family-4 (IRF4) Expression in Newly Diagnosed Patients with Multiple Myeloma
Indian Journal of Hematology and Blood Transfusion Open Access 16 January 2023
-
The dynamic functions of IRF4 in B cell malignancies
Clinical and Experimental Medicine Open Access 10 December 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, S., Nakazawa, N., Iida, S. et al. Detection of MUM1/IRF4-IgH fusion in multiple myeloma. Leukemia 13, 1812–1816 (1999). https://doi.org/10.1038/sj.leu.2401563
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401563
Keywords
This article is cited by
-
Clinical Relevance of Interferon Regulatory Family-4 (IRF4) Expression in Newly Diagnosed Patients with Multiple Myeloma
Indian Journal of Hematology and Blood Transfusion (2023)
-
The dynamic functions of IRF4 in B cell malignancies
Clinical and Experimental Medicine (2022)
-
Molecular interactions of IRF4 in B cell development and malignancies
Biophysical Reviews (2021)
-
IRF4 promotes cell proliferation by JNK pathway in multiple myeloma
Medical Oncology (2013)
-
IRF4 Expression without IRF4 Rearrangement Is a General Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Journal of Investigative Dermatology (2010)